Some regions say temporarily pausing the use of AstraZeneca’s vaccine in Sweden will delay their inoculation programs greatly.

The Public Health Agency said it was halting the drug for the time being as a precaution over concerns of possible side affects.

The suspension will remain until the European Medicines Agency issues its findings from an investigation into the drug due later this week.


Similar articles:

Leave a Reply

Your email address will not be published. Required fields are marked *